Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySun, 30 Jun 2024 05:36:26 +0200Thu, 23 May 2024 15:41:00 +0200Human medicines European public assessment report (EPAR): Tizveni, tislelizumab, Date of authorisation: 19/04/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tizveniHuman medicines European public assessment report (EPAR): Tizveni, tislelizumab, Date of authorisation: 19/04/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/tizveniThu, 23 May 2024 15:41:00 +0200Human medicineTizveni : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-005542-en.pdfTizveni : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-005542-en.pdfThu, 23 May 2024 14:58:00 +0200Human medicine